Platform
Features
NextPhase Therapeutics
Contact
Scientific Researcher at UDC. Several PCT patents and more than 40 papers in peer review journals. One approved drug based on MSC.
Manuel Hermida
Chief Science Officer
Sign up to view 1 direct report
Get started
2 members
Ro5
CytomX
Roche
NanoSpy, Inc.
Cogent Biosciences